MedTrace Logo

Assessment of Dermatologic Family Impact Scale in the Parents of Children With Psoriasis

NCT02796014 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 129

Last updated 2017-08-21

No results posted yet for this study

Summary

The Dermatological Diseases Family Impact Scale (DeFIS) was developed to assess different aspects of health-related quality of life in the relatives of the patients with various skin diseases. The preliminary validation of this instrument was performed for the Turkish population. In the pilot study, this 15-item-questionnaire was shown to be easy to complete and score, and reliably help to evaluate the family members' quality of life.

Psoriasis is a chronic disease which can be expected to have a significant impact on the quality of life of the patients and parents/family members alike. In line with this assumption, previous studies demonstrated that psoriasis psychosocially affects not only the patients, but also their close relatives. The psoriasis family index has been developed in an effort to objectively measure the health-related quality of life of the family members of patients with psoriasis. Nevertheless, data regarding the health-related quality of life of the parents of pediatric patients with psoriasis in the Turkish population are relatively scarce.

In study, the investigators primarily aim to utilize DeFIS to assess the impact of childhood psoriasis on the quality of life of the patients' parents. Further, the investigators attempt to investigate the relation between the quality of life of the patients and their parents, and reveal disease characteristics which might influence the quality of life.

Conditions

Sponsors & Collaborators

  • Bakirkoy Dr. Sadi Konuk Research and Training Hospital

    collaborator OTHER_GOV

  • Haseki Training and Research Hospital

    collaborator OTHER

  • Haydarpasa Numune Training and Research Hospital

    collaborator OTHER

  • Istanbul Training and Research Hospital

    collaborator OTHER_GOV

  • Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization

    collaborator OTHER

  • Sisli Hamidiye Etfal Training and Research Hospital

    collaborator OTHER

  • Istanbul Medeniyet University

    lead OTHER

Principal Investigators

  • Burak Tekin, M.D. · Istanbul Medeniyet University Goztepe Research and Training Hospital Department of Dermatology

Eligibility

Min Age
3 Months
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-05-31
Primary Completion
2017-03-31
Completion
2017-03-31

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02796014 on ClinicalTrials.gov